China Influenza AB/COVID/RSV COMBO RAPID TEST
Product Details
| Brand | QL |
|---|---|
| Certificate | CE / TGA / ISO13485/UK Registration |
| Specimen | Nasal swab |
| Pack | 1 test, 5 tests, 20 tests |
| Reading Time | 10 Minutes |
| Contents | Cassette, Sterile Nasal Swab, Buffer, Package Insert |
| Storage | 2-30℃ |
| Shelf Life | 2 Years |
Common Product Specifications
| Sensitivity | 90.91% |
|---|---|
| Specificity | 100.00% |
| Total Coincidence Rate | 98.21% |
Product Manufacturing Process
According to authoritative papers, the China Influenza AB/COVID/RSV COMBO RAPID TEST employs advanced immunoassay technologies. The process involves coating antibodies on nitrocellulose membranes, ensuring high specificity and sensitivity in detecting viral antigens. Rigorous testing and quality control measures align with international standards, offering reliable diagnostic performance for healthcare providers. The manufacturing process prioritizes precision and accuracy, contributing to the test's effectiveness in clinical settings.
Product Application Scenarios
References from authoritative sources highlight the utility of the China Influenza AB/COVID/RSV COMBO RAPID TEST in diverse healthcare settings. Its rapid turnover is crucial in emergency departments and clinics, where immediate decision-making impacts patient management and infection control. The test's ability to differentiate between similar respiratory infections enhances its application in public health surveillance, aiding timely interventions and reducing viral spread in the community.
Product After-Sales Service
QL Biotech offers comprehensive after-sales support for the China Influenza AB/COVID/RSV COMBO RAPID TEST, including detailed product guides, troubleshooting assistance, and expert consultations to ensure optimal test usage and interpretation.
Product Transportation
The tests are transported in temperature-controlled conditions to maintain their integrity and performance. Shipping aligns with global standards to ensure timely and safe delivery.
Product Advantages
- Speed: Provides results within 10 minutes for rapid clinical decision-making.
- Convenience: Usable in various settings without specialized equipment.
- Comprehensive: Simultaneously tests for multiple viruses, conserving resources.
Product FAQ
- Q: How accurate is the China Influenza AB/COVID/RSV COMBO RAPID TEST? A: It offers a sensitivity of 90.91% and specificity of 100.00%, providing reliable results.
- Q: Can it differentiate between multiple infections at once? A: Yes, it simultaneously detects Influenza A, B, COVID-19, and RSV, aiding complex diagnostics.
- Q: What age group can use this test? A: It's suitable for individuals aged 15-70, with or without assistance.
- Q: How should the sample be collected? A: Use a nasal swab, ensuring maximum secretion collection for accuracy.
- Q: Are there any storage requirements? A: Store between 2-30℃ for optimal performance.
- Q: How is the test disposed of? A: Follow biohazard waste guidelines for all materials.
- Q: Is special training required to administer the test? A: Minimal training is needed, ensuring ease of use in varied settings.
- Q: What is the shelf life of the test? A: It has a shelf life of up to 2 years.
- Q: Can it detect other viruses apart from the specified ones? A: The test is designed specifically for Influenza A, B, COVID-19, and RSV.
- Q: How does it contribute to public health management? A: Early detection informs strategies like vaccination drives and isolation measures.
Product Hot Topics
- China Influenza AB/COVID/RSV COMBO RAPID TEST: A Revolution in Rapid Diagnostics The introduction of the China Influenza AB/COVID/RSV COMBO RAPID TEST marks a significant advancement in the rapid diagnostics field. Its ability to quickly identify and differentiate between major viral infections speaks to its importance in modern healthcare. Especially during overlapping flu and COVID-19 seasons, its contribution to controlling outbreaks is invaluable. Healthcare providers and public health officials can rely on its precision and speed to make informed decisions.
- Enhancing Patient Care with China Influenza AB/COVID/RSV COMBO RAPID TEST As healthcare systems strive for efficiency, the China Influenza AB/COVID/RSV COMBO RAPID TEST plays a crucial role. By delivering fast, accurate results, it allows for immediate clinical responses, reducing the strain on hospitals and improving patient outcomes. Its use in frontline settings demonstrates its versatility and importance in today’s health landscape.
Image Description
